ePrivacy and GPDR Cookie Consent by Cookie Consent Industry sponsored sessions | 18th European AIDS Conference

Industry sponsored sessions

Change does not mean stagnation

  • New format does not mean you should lose out on crucial knowledge.
  • Top experts in the field will be reviewing recent trials and findings which will shape the future of clinical practice.
  • Stay up to speed with the latest data on HIV developments and innovative solutions.
Wednesday, October 27

11:00 – 12:00,  room CAPITAL SUITE 14

Industry Sponsored Session – Virology Education

Immune Non-Responders: A Remaining Unmet Need

Chair: Anton Pozniak (United Kingdom)

Introduction

Anton Pozniak (United Kingdom)

11:00 - 11:05

Mechanisms of poor immune reconstitution in HIV patients

Peter Hunt (USA)

11:05 - 11:20

Potential role of specific drugs in immune reconstitution

Walther Mothes (USA)

11:20 - 11:35

CD4 responses in trials of highly treatment experienced patients

Antonella Castagna (Italy)

11:35 - 11:50

Discussion, Q&A, Closure

11:50 - 12:00

12:30 – 13:30,  room CAPITAL SUITE 14

Industry Sponsored Session– Janssen

Learning outcomes: HIV and SARS-CoV-2: Two entangled epidemics

Chair: Esteban Martinez (Spain)

Welcome and introduction

Esteban Martinez (Spain)

12:30 - 12:35

Expert Insights presentation: Impact of COVID-19 on 90-90-90-90:

Perspective from Lombardy region

Silvia Nozza (Italy)

12:35 – 12:45

Expert Insights presentation: COVID-19 as an opportunity for the `new normal'

Karine Lacombe (France)

12:45 – 12:55

Patient Insights presentation: Experiences of living with HIV during the pandemic

Mario Cascio (Italy)

12:55 – 13:05

Panel discussion: What learnings can we take from COVID-19 to inform the future management of people living with HIV?

All

13:05 – 13:25

Summary and close

Esteban Martinez (Spain)

13:25 - 13:30

13:30 - 15:00,  room HALL S11

Industry Sponsored Session– MSD

Forty years later… Where are we now in the HIV Journey?

Chair: Anton Pozniak (United Kingdom)

Opening / Welcome

Anton Pozniak (United Kingdom)

13:30 – 13:35

Are we there yet?

Jürgen Rockstroh (Germany)

13:35 - 13:50

Practical considerations about metabolic issues in PLWH

Jordan Lake (USA)

13:50 - 14:05

Leaving no one behind

Andrew Ustianowsky (United Kingdom)

14:05 - 14:20

Individualization of treatment: Living Well with HIV (Case Discussion)

Ana Milinkovic (United Kingdom)

14:20 - 14:40

Panel Discussion and Q&A 14:40 - 15:00

14:00 - 15:30,  room CAPITAL SUITE 14

Industry Sponsored Session – Gilead
(organized by Clinical Care Options)

Individualized Choices in Antiretroviral Therapy: Present and Future

Chair: Chloe Orkin (United Kingdom)

Overview of Current Patient-Centered ART

Chloe Orkin (United Kingdom)

14:00 – 14:15

Case-Based Discussion: Putting Individualized Care Into Practice

  • Chloe Orkin (United Kingdom)
  • Jean-Michel Molina (France)
  • Cristina Mussini (Italy)
14:15 - 15:00

Future ART: Closing the Remaining Gaps

Jean-Michel Molina (France)

15:00 - 15:10

Question and Answers 15:10 - 15:30

16:15 - 17:15, room CAPITAL SUITE 12

Industry Sponsored Session – Thera Technologies

Taking a new approach:
Therapeutic options for highly treatment-experienced HIV-1 patients

Chair: Graeme Moyle (United Kingdom)

Welcome and introductions

Graeme Moyle (United Kingdom)

16:15 - 16:20

Understanding the challenges of highly treatment-experienced HIV-1 patients

Antonella Castagna (Italy)

16:20 -16:35

A virologist’s perspective on management

Anne-Geneviève Marcelin (France)

16:35 - 16:50

Building an optimised regimen: The impact of drug-drug interactions

David Back (United Kingdom)

16:50 - 17:05

Discussion and Q&A

All faculty,  Q&A facilitated by Graeme Moyle (United Kingdom)

17:05 - 17:15

Thursday, October 28

07:30 - 08:30, room HALL S11

Industry Sponsored Session – MSD

Forging new paths together to address unmet needs in HIV

Chair: Graeme Moyle (United Kingdom)

Opening/Welcome

Ian Hodgson (United Kingdom)

07:30 -07:40

Lessons to learn from the COVID-19 pandemic

  • Moderator: Ian Hodgson (United Kingdom)
  • Panelists Denis Onyango (United Kingdom), Susan Cole Haley (United Kingdom)

07:40 - 08:00

Successful collaboration in HIV (presentation)

  • Moderator: Ian Hodgson (United Kingdom)
  • Panelists Denis Onyango (United Kingdom), Susan Cole Haley (United Kingdom)

08:00 -08:10

Advancing policy change

  • Moderator: Ian Hodgson (United Kingdom)
  • Panelists Denis Onyango (United Kingdom), Susan Cole Haley (United Kingdom)
08:10 - 08:25

Closing

Ian Hodgson (United Kingdom)

08:25 - 08:30

12:00 - 13:00, room HALL S11

Industry Sponsored Session – Gilead

Beyond undetectable: Aiming for long-term treatment success in people living with HIV

Chair: Alan Winston (United Kingdom)

Welcome and introduction

Alan Winston (United Kingdom)

12:00 -12:10

Back to “normal”: Re-initiating conversations around what success looks like in long-term management of PLWH

Alan Winston (United Kingdom)

12:10 - 12:20

Attaining long-term treatment success with B/F/TAF: What are the data telling us?

  • Alan Winston (United Kingdom)
  • Sorana Segal-Maurer (USA)
  • Giovanni Guaraldi (Italy)
  • Christoph Boesceke (Germany)
12:20 - 12:35

B/F/TAF in clinical practice; The added value of real-world evidence 12-month BICSTaR data

  • Alan Winston (United Kingdom)
  • Sorana Segal-Maurer (USA)
  • Giovanni Guaraldi (Italy)
  • Christoph Boesceke (Germany)

Potentially other ISR data

12:35 - 12:50

 Live Q&A with expert faculty panel

  • Alan Winston (United Kingdom)
  • Sorana Segal-Maurer (USA)
  • Giovanni Guaraldi (Italy)
  • Christoph Boesceke (Germany)

12:50 -13:00

17:30 - 19:00, room HALL S11

Industry Sponsored Session – ViiV Healthcare

The Time for Long-Acting Is Now

Chairs: Peter Reiss (The Netherlands), Jean van Wyk (United Kingdom)

Welcome and introduction

  • Peter Reiss (The Netherlands)
  • Jean van Wyk (United Kingdom)
17:30 - 17:40

The key attributes – long-acting therapy

Marta Boffito (United Kingdom)

17:45 - 18:00

The evidence – efficacy, safety and patient-reported outcomes

Chloe Orkin (United Kingdom)

18:00 - 18:15

The implementation – getting started with long-acting therapy

Hans Jäger (Germany)

18:15- 18:30

Patient experience with long-acting therapy

18:30 - 18:35

Panel discussion:

  • Chloe Orkin (United Kingdom)
  • Marta Boffito (United Kingdom)
  • Hans Jäger (Germany)

Moderators: Peter Reiss (The Netherlands) and Jean van Wyk (United Kingdom)  

18:35 - 18:50

Summary and close

Peter Reiss (The Netherlands)

18:50 - 19:00
Friday, October 29

12:00 - 13:30, room HALL S11

Industry Sponsored Session – ViiV Healthcare

Let’s talk about choices: putting people first

Chairs: Nneka Nwokolo (United Kingdom)

Welcome and introduction

Nneka Nwokolo (United Kingdom)

12:00 - 12:05

Addressing the treatment challenges of today’s HIV community

  • Garry Brough (United Kingdom)
  • Nneka Nwokolo (United Kingdom)

12:05 - 12:10

Bringing people living with HIV into the conversation

  • David Hardy (USA)
  • Josep M Llibre (Spain)
  • Justyna Kowalska (Poland)
  • Nneka Nwokolo (United Kingdom)
12:10 - 12:50

Live Q&A

  • David Hardy (USA)
  • Josep M Llibre (Spain)
  • Justyna Kowalska (Poland)
  • Nneka Nwokolo (United Kingdom)
12:50-13:05

Summary and close

Nneka Nwokolo (United Kingdom)

13:05 - 13:10

17:30 - 18:30, room HALL S11

Industry Sponsored Session – Gilead

Re-imagining Person-Centered HIV Care:

Clinical and System Considerations in a Pandemic Transformed World

Chairs: Anne Aslett (United Kingdom)

Chair’s welcome and introduction

Anne Aslett (United Kingdom)

17:30 - 17:45

Changing the conversation: How has the COVID-19 pandemic impacted HIV clinical care and health system supports?

Case studies:

  • Jeff Lazarus (Spain)
  • Jane Anderson (United Kingdom)

Facilitated discussion:

  • Anne Aslett (United Kingdom)
  • Jeff Lazarus (Spain)
  • Jane Anderson (United Kingdom)
  • Nikos Dedes (Greece)
  • Keletso Makofane (South Africa)

17:45 - 18:00

Post-pandemic environment, disease management and monitoring: What will change for the better?

Case studies:

  • Nikos Dedes (Greece)
  • Keletso Makofane (South Africa)

Facilitated discussion:

  • Anne Aslett (United Kingdom)
  • Jeff Lazarus (Spain)
  • Jane Anderson (United Kingdom)
  • Nikos Dedes (Greece)
  • Keletso Makofane (South Africa)
18:00 -18:15

Live audience Q&A

  • Anne Aslett (United Kingdom)
  • Jeff Lazarus (Spain)
  • Jane Anderson (United Kingdom)
  • Nikos Dedes (Greece)
  • Keletso Makofane (South Africa)
18:15- 18:25

Session close

Anne Aslett (United Kingdom)

18:25 -18:30

Registration

Register now

Scientific programme

Explore it

Conference synopses

Discover the line-up

COVID-19 & travel

Our latest updates